Found: 28
Select item for more details and to access through your institution.
Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 247, doi. 10.2147/PGPM.S130247
- By:
- Publication type:
- Article
Ethiopian health care professionals' knowledge, attitude, and interests toward pharmacogenomics.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 279, doi. 10.2147/PGPM.S145336
- By:
- Publication type:
- Article
Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 267, doi. 10.2147/PGPM.S87945
- By:
- Publication type:
- Article
Pharmacogenomics of sickle cell disease: steps toward personalized medicine.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 261, doi. 10.2147/PGPM.S123427
- By:
- Publication type:
- Article
Pharmacogenomics of sickle cell disease: steps toward personalized medicine.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 261, doi. 10.2147/PGPM.S123427
- By:
- Publication type:
- Article
Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 253, doi. 10.2147/PGPM.S141935
- By:
- Publication type:
- Article
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 243, doi. 10.2147/PGPM.S143250
- By:
- Publication type:
- Article
ABCBI and ABCCI single-nucleotide polymorphisms in patients treated with clozapine.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 235, doi. 10.2147/PGPM.S142314
- By:
- Publication type:
- Article
Updating the landscape of direct-to-consumer pharmacogenomic testing.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 229, doi. 10.2147/PGPM.S140461
- By:
- Publication type:
- Article
Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 233, doi. 10.2147/PGPM.S146787
- By:
- Publication type:
- Article
CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 217, doi. 10.2147/PGPM.S136341
- By:
- Publication type:
- Article
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 209, doi. 10.2147/PGPM.S140700
- By:
- Publication type:
- Article
Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 197, doi. 10.2147/PGPM.S109648
- By:
- Publication type:
- Article
Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 187, doi. 10.2147/PGPM.S123376
- By:
- Publication type:
- Article
CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 183, doi. 10.2147/PGPM.S129908
- By:
- Publication type:
- Article
ABCB1 genetic variants in leukemias: current insights into treatment outcomes.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 169, doi. 10.2147/PGPM.S105208
- By:
- Publication type:
- Article
DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 157, doi. 10.2147/PGPM.S132691
- By:
- Publication type:
- Article
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 143, doi. 10.2147/PGPM.S108123
- By:
- Publication type:
- Article
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 129, doi. 10.2147/PGPM.S105854
- By:
- Publication type:
- Article
Pharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 115, doi. 10.2147/PGPM.S131580
- By:
- Publication type:
- Article
CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 107, doi. 10.2147/PGPM.S126305
- By:
- Publication type:
- Article
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 79, doi. 10.2147/PGPM.S125452
- By:
- Publication type:
- Article
MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 69, doi. 10.2147/PGPM.S107047
- By:
- Publication type:
- Article
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 61, doi. 10.2147/PGPM.S108656
- By:
- Publication type:
- Article
Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 39, doi. 10.2147/PGPM.S114211
- By:
- Publication type:
- Article
Prevalence of clinically actionable genotypes and medication exposure of older adults in the community.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 17, doi. 10.2147/PGPM.S123719
- By:
- Publication type:
- Article
Diet and lifestyle factors associated with miRNA expression in colorectal tissue.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 1, doi. 10.2147/PGPM.S117796
- By:
- Publication type:
- Article
The HLA-A*31:01 allele: influence on carbamazepine treatment.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 29, doi. 10.2147/PGPM.S108598
- By:
- Publication type:
- Article